{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-138446","form_type":"8-K","ticker":"ENGN","cik":"0001980845","company_name":"enGene Therapeutics Inc.","filed_at":"2024-12-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.516172+00:00","generated_at":"2026-05-29T01:48:39.819170+00:00","sec_items":["1.01","2.02","2.03","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"enGene reports FY2024 net loss $55.1M; cash $297.9M; LEGEND study on track for mid-2026 BLA","bullets":["Net loss $55.1M ($1.46/sh) vs $104.7M in FY2023; operating expenses $62.3M up from $26.1M.","Cash, cash equivalents and marketable securities $297.9M; expected to fund operations into 2027.","Preliminary LEGEND pivotal data: 71% anytime CR rate in BCG-unresponsive NMIBC with CIS; BLA filing on track for mid-2026.","First Amendment with Hercules Capital reallocates $7.5M to Tranche 3; total $50M facility unchanged.","Appointed Joan Connolly as CTO, Anthony Cheung as CSO, Alex Nichols as Chief Strategy & Operations Officer."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-138446","json":"https://secwatch.observer/filing/0000950170-24-138446.json","markdown":"https://secwatch.observer/filing/0000950170-24-138446.md","text":"https://secwatch.observer/filing/0000950170-24-138446.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1980845/000095017024138446/0000950170-24-138446-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1980845/000095017024138446/engn-20241219.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T01:48:39.819170+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}